Portal de investigación
ESTUDIO ABIERTO, DE EXTENSIÓN, A LARGO PLAZO, CON TOFACITINIB (CP-690,550) PARA EL TRATAMIENTO DE LA ARTRITIS PSORIÁSICA. NUMEROS DE LOS PLANES PEDIÁTRICOS DE INVESTIGACIÓN - (P/144/2010),(P/162/2011) Y (P/0064/2012).
Datos básicos
- Protocolo:
- A3921092
- EUDRACT:
- 2011-002169-39
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2014
- Año de finalización:
Documentos
- No hay documentos
Participantes
-
José Andrés Román Ivorra
Investigador Principal
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
Capítulo 10. Artritis psoriásica. Concepto, manifestaciones clínicas, analítica y radiología
FRAGIO, J.; (...); ROMÁN, J.
Capítulo de un Libro. 2019
Capítulo 11. Concepto y clasificación de las enfermedades autoinmunes
AREVALO, K.; (...); ROMÁN, J.
Capítulo de un Libro. 2017
"Comments on: Clinical implementation of a new electronic brachytheropy system for skin brachytheropy" Reply
Pons-Llanas O; (...); Perez-Calatayud J
Letter. 10.5114/jcb.2015.53991. 2015
"Mojito's" phytophotodermatitis, the other "lime" disease
Torres-Navarro, I, Condiño-Brito E, Botella-Estrada, R
Editorial Material. 10.1016/j.medcli.2017.08.008. 2018
"Phytophotodermatitis as a clinical problem and as a therapeutic option: case report and review of the literature".
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1016/j.pdpdt.2023.103304. 2023
[[Tranaslated article]]Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.
López DF; (...); Ortiz-Romero, P. L.
Article. 10.1016/j.ad.2022.11.013. 2023
[[Translated article]]Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).
Couselo-Rodríguez C; (...); Flórez Á
Article. 10.1016/j.ad.2023.07.028. 2024
[[Translated article]]Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
Sanchez-Diaz, M; (...); Carrascosa-Carrillo, J M
Article. 10.1016/j.ad.2024.01.019. 2024
[Farewell open letter to SEFH members].
Editorial Material. 10.7399/fh.2015.39.6.10128. 2015
[Translated article] BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.
Munera-Campos M; (...); Carrascosa JM
Article. 10.1016/j.ad.2023.05.010. 2023
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Fatal outcome in classic Kaposi's sarcoma.
Mansilla-Polo M, Botella-Estrada R
Article. 10.1016/j.ad.2024.03.015. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.
Nieto Benito, L M; (...); Garcia-Doval, I
Article. 10.1016/j.ad.2021.05.027. 2022
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
[Translated article] Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer - Basal Cell Carcinoma or Squamous Cell Carcinoma - Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
Minano Medrano, R.; (...); Garcia-Doval, I
Article. 10.1016/j.ad.2022.01.035. 2022
18 FDG PET/CT PREDICTS DECLINE IN FUNCTIONAL RESPIRATORY TESTS IN SYSTEMIC SCLEROSIS PATIENTS BUT NOT IN RHEUMATOID ARTHRITIS PATIENTS
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6844. 2018
18 FDG PET/CT Predicts Decline in Functional Respiratory TESTS in Systemic Sclerosis Patients but NOT in Rheumatoid Arthritis Patients
Gil, JJF; (...); Ivorra, JAR
Meeting Abstract. 2017
18 F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with polymyalgia rheumatica: Screening for vasculitis.
Arévalo Ruales K; (...); Román Ivorra JA
Article. 10.1016/j.reuma.2018.02.009. 2020
18f-FDG-PET/CT for Giant Cell Arteritis Detection of Large Vessel Vasculitis: What Should We Take into Consideration? Analytical Study of the Arteser Registry
Estrada-Alarcon, Paula V.; (...); Blanco, Ricardo
Meeting Abstract. 2023
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
Torres-Navarro I; (...); Botella-Estrada R
Letter. 10.1111/jdv.16664. 2020
A Case of Localised Immediate Hypersensitivity Reaction to Bimekizumab.
Lasheras-Perez, Miguel Antonio; (...); Ibanez-Echevarria, Ethel
Article. 10.1111/cod.14774. 2025
A Composite Indicator to Assess the Quality of Care in the Management of Patients With Rheumatoid Arthritis in Outpatient Rheumatology Clinics.
Martin-Martinez MA; (...); Vela-Casasempere P
Article. 10.1016/j.reuma.2017.06.017. 2019
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Lopez-Isac, E; (...); Spanish Scleroderma Grp
Article. 10.1186/ar4432. 2014
A Multicenter Series of Giant Cell Arteritis Patients from Clinical Practice in Treatment with Tocilizumab Compared with Giacta Trial
Goercke, MC; (...); Blanco, R
Meeting Abstract. 2018
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Casado, MA; (...); Grp MULTIDEX-EMD
Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A Pseudoxanthoma Elasticum-Like Papular Eruption: Challenge.
Sabater-Marco V, Sanz-Motilva V, Botella-Estrada R
Article. 10.1097/DAD.0000000000000489. 2017
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
Dirschka T; (...); Puig S
Article. 10.1111/jdv.15185. 2019
A review of terms used to define cutaneous squamous cell carcinoma with a poor prognosis
Canueto, J; (...); Sanmartin, O
Review. 10.1016/j.ad.2019.06.005. 2020
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
Megías-Vericat JE; (...); Aliño SF
Article. 10.1038/tpj.2015.80. 2016
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients.
Fernández-Díaz C; (...); Blanco R
Article. 10.1093/rheumatology/keaa621. 2020
ABATACEPT IN MONOTHERAPY VERSUS COMBINED IN INTERSTITIAL LUNG DISEASE OF RHEUMATOID ARTHRITIS. MULTICENTER STUDY OF 263 CAUCASIAN PATIENTS
Fernandez-Diaz, C; (...); Blanco, R
Meeting Abstract. 10.1136/annrheumdis-2021-eular.892. 2021
ABATACEPT IN MONOTHERAPY VERSUS COMBINED IN INTERSTITIAL LUNG DISEASE OF RHEUMATOID ARTHRITIS. MULTICENTER STUDY OF 263 CAUCASIAN PATIENTS.
Fernandez-Diaz, Carlos; (...); Spanish Collaborative Group of Interstitial Lung Disease Associated with Rheumat
Article. 10.1093/rheumatology/keab317. 2022
Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients
Fernandez-Diaz, C; (...); Blanco, R
Review. 10.1016/j.semarthrit.2017.12.012. 2018
ABATACEPT IN RHEUMATOID ARTHRITIS WITH INTERSTITIAL LUNG DISEASE. A MULTICENTRE STUDY OF 181 PATIENTS
Fernandez-Diaz, C; (...); Blanco, R
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6091. 2019
Abatacept in Rheumatoid Arthritis with Interstitial Lung Disease: A Retrospective Multicenter Study of 263 Patients
Fernandez-Diaz, C.; (...); Blanco, Ricardo
Meeting Abstract. 2019
ABATACEPT IN USUAL AND IN NON-SPECIFIC INTERSTITIAL PNEUMONIA ASSOCIATED TO RHEUMATOID ARTHRITIS. NATIONAL MULTICENTER STUDY OF 190 PATIENTS
Atienza-Mateo, B; (...); Blanco, R
Meeting Abstract. 10.1136/annrheumdis-2021-eular.711. 2021
Abatacept in Usual and in Non-Specific Interstitial Pneumonia Associated to Rheumatoid Arthritis. National Multicenter Study of 190 Patients
Atienza-Mateo, Belen; (...); Blanco, Ricardo
Meeting Abstract. 2021
Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis
Atienza-Mateo B; (...); Blanco R
Article. 10.1016/j.ejim.2023.08.025. 2024
Abatacetp in Spanish Patients with Arthritis Rheumatoid and Interstitial Lung Disease. Multicenter Study of 263 Patients
Fernandez-Diaz, C; (...); Blanco, R
Meeting Abstract. 2020
Aberrant DNA methylation is associated with aggressive clinicopathological features and poor survival in cutaneous melanoma
de Unamuno Bustos, B; (...); Botella Estrada, R
Article. 10.1111/bjd.16254. 2018
Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis
Torres-Navarro, I; (...); Botella-Estrada, R
Article. 10.1111/1346-8138.15490. 2020
Accuracy of SCORTEN to predict the prognosis of Stevens-Johnson syndrome/toxic epidermal necrolysis: a systematic review and meta-analysis
Torres-Navarro, I, Briz-Redon, A, Botella-Estrada, R
Review. 10.1111/jdv.16137. 2020
ACR/EULAR 2022 Classification Criteria Compared to the ACR 1990 Classification Criteria in the ARTESER Registry of Giant Cell Arteritis
De Miguel, Eugenio; (...); Blanco-Alonso, Ricardo
Meeting Abstract. 2024
Acute Necrotic Plaque in an Immunocompromised Host
Sahuquillo-Torralba, A; (...); Botella-Estrada, R
Editorial Material. 10.1097/DAD.0000000000000470. 2017
Acute Necrotic Plaque in an Immunocompromised Host
Sahuquillo-Torralba, A; (...); Botella-Estrada, R
Editorial Material. 10.1097/DAD.0000000000000471. 2017
ACUTE PARAPARESIS AS CLINICAL PRESENTATION OF VERTEBRAL OSTEOMYELITIS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6662. 2019
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Advanced type 1 hyperoxaluria presenting as livedo racemosa in a patient with end-stage renal disease
Torres-Navarro, I; (...); Moral-Moral, P
Letter. 10.4103/ijdvl.IJDVL_1030_18. 2019
Aflibercept in exudative age related macular degeneration refractory to ranibizumab.
Ruiz Ramos J; (...); Gallego-Pinazo R
Article. 10.1016/j.oftal.2015.07.018. 2015
After JAK Inhibitor Failure, "Switching" or "Cycling"?
Munoz Martinez, Pablo Francisco; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
AFTER JAK INHIBITOR FAILURE, 'SWITCHING' OR 'CYCLING'?
Munoz Martinez, P.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4124. 2023
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort
López-Isac E; (...); Martín J
Editorial Material. 10.1002/art.40058. 2017
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
ANALYSIS OF THE MUSCULOSKELETAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS AND ITS RELATIONSHIP WITH BIOLOGICAL TREATMENT
Mendoza, SM; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5687. 2017
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
ANNALYSIS OF PRO-INFLAMMATORY BIOMARKERS IN A POLYMYALGIA RHEUMATICA COHORT DURING THE ACUTE ONSET OF THE DISEASE
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.3114. 2021
ANTIMALARIAL DRUGS AND ELECTROCARDIOGRAPHIC ALTERATIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
Barcena, C. Riesco; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2847. 2022
Anti-Mi-2 Dermatomyositis with ulcerative plaques.
Palacios-Diaz RD; (...); Botella-Estrada, Rafael
Article. 10.1093/rheumatology/keac180. 2022
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ruiz, J; (...); Catellanos, A
Article. 10.1016/j.medin.2017.07.002. 2018
ANTI-RO52 KDa and ANTI-RO60 KDa Analysis in Systemic LUPUS Erythematous Patients to Detect ANTI-RO False-Negatives
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 2017
ANTI-RO52 KDA AND ANTI-RO60 KDA ANALYSIS IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS TO DETECT ANTI-RO FALSE-NEGATIVES
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5758. 2017
Antitumor Cell-Complex Vaccines Employing Genetically Modified Tumor Cells and Fibroblasts
Miguel A; (...); Aliño SF
Article. 10.3390/toxins6020636. 2014
Apremilast for Refractory Mucocutaneous Ulcers of Behcet's Disease. National Multicenter Study of 14 Cases
Atienza-Mateo, B; (...); Blanco, R
Meeting Abstract. 2017
Apremilast in Combination vs Monotherapy for Refractory Oral And/or Genital Ulcers in Behcet's Disease: National Multicenter Study of 51 Cases
Atienza-Mateo, Belen; (...); Blanco, Ricardo
Meeting Abstract. 2019
APREMILAST IN MONOTHERAPY OR COMBINED IN NON-ULCER MANIFESTATIONS OF BEHCET'S DISEASE. NATIONAL MULTICENTER STUDY OF 34 REFRACTORY CASES OF CLINICAL PRACTICE
Morant, AH; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2020-eular.4720. 2020
Apremilast in Refractory Oral and/or Genital Ulcers in Behcet's Disease. Multicenter Study of 37 Cases
Atienza-Mateo, B; (...); Blanco, R
Meeting Abstract. 2018
Apremilast in refractory orogenital ulcers and other manifestations of Behcet's disease. A national multicentre study of 51 cases in clinical practice
Atienza-Mateo, B.; (...); Blanco, R.
Article. 2020
Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. A national multicentre study of 51 cases in clinical practice.
Atienza-Mateo B; (...); Blanco R
Article. 2020
Aqueous Humor Levels of Different Interleukins 1-beta, 2, 6 and 10, Tumor Necrosis Factor-alpha and Vascular Endothelial Growth Factor in Uveitis Treated with Adalimumab.
Hernandez Garfella ML; (...); Cervera Taulet E
Article. 10.4103/2008-322X.156110. 2015
ASSESMENT OF CLINICAL AND RADIOLOGICAL PROGNOSTIC VARIABLES IN PATIENTS WITH SPONDYLODISCITIS
Gil, JJF; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5891. 2017
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic
Roca-Gines, J; (...); Evole-Buselli, M
Article. 10.1001/jamadermatol.2020.2340. 2020
Assessment of the quality of sample labelling for clinical research.
Pérez-Huertas P; (...); Poveda-Andrés JL
Article. 10.7399/fh.2016.40.2.9753. 2016
ASSOCIATION BETWEEN CARDIOVASCULAR RISK FACTORS AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
Mazario, RG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5868. 2017
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study
Avallone, Gianluca; (...); Quaglino, Pietro
Article. 10.2340/actadv.v102.319. 2022
Association of Anti-CarP Levels with Clinical Activity and Serological Profile in Rheumatoid Arthritis
Martinez Calabuig, Pablo; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Asymptomatic Annular Plaques in a 67-Year-Old Man
de Unamuno Bustos B; (...); Estrada, RB
Article. 10.1097/DAD.0000000000000507. 2017
Asymptomatic Annular Plaques in a 67-Year-Old Man: Challenge.
de Unamuno Bustos B; (...); Estrada RB
Article. 10.1097/DAD.0000000000000506. 2017
AUTOANTIBODY PROFILE ANALYSIS AND ITS ASSOCIATION WITH CLINICAL MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5699. 2019
Autologous stem cell transplantation in systemic sclerosis: 4 cases.
de la Rubia Navarro, Marta, Leal Rodriguez, Samuel, Roman Ivorra, Jose Andres
Article. 10.1016/j.reumae.2025.501810. 2025
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
BASELINE PROFILE OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS ON TREATMENT WITH BELIMUMAB OF A SPANISH MULTICENTER COHORT
Altabas Gonzalez, I.; (...); Rua-Figueroa, I.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3003. 2023
Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
BELIMUMAB IV EFFECT IN GLUCOCORTICOID TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Navarro, MD; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6585. 2019
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
BIOBADATOP Spanish Atopic Dermatitis Registry: Description and Early Findings.
Munera-Campos M; (...); Carrascosa JM
Article. 10.1016/j.ad.2023.03.001. 2023
Biosimilares: viejas polemicas con nuevos argumentos.
Poveda-Andrés JL, Bosó-Ribelles V
Editorial Material. 10.7399/fh.2015.39.3.8978. 2015
BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population
Perez-Huertas, P; (...); Poveda-Andres, JL
Article. 10.1177/1043454216631952. 2017
BLYS UPREGULATION IS RELATED TO LYMPHOPENIA IN SYSTEMIC ERYTHEMATOUS LUPUS PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.4186. 2017
BONE METABOLISM AND OSTEOPOROSIS RISK FACTORS ANALYSIS IN SPINAL CORD INJURY PATIENTS
Grau Garcia, E.; (...); Roman Ivorra, J.
Meeting Abstract. 10.1136/annrheumdis-2016-eular.5086. 2016
BONE METABOLISM AND OSTEOPOROSIS RISK FACTORS ANALYSIS IN SPINAL CORD INJURY PATIENTS AT TWELVE MONTHS FOLLOW UP
Cordellat, IM; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5487. 2017
BONE Metabolism in LIVER Transplant Patients Two-Year Study. Influence of Medical Intervention PRIOR to Surgery and Antiresorptive Treatment
Sanchez, EL; (...); Ivorra, JAR
Meeting Abstract. 2017
BONE METABOLISM IN LIVER TRANSPLANT PATIENTS TWO-YEAR STUDY. INFLUENCE OF MEDICAL INTERVENTION PRIOR TO SURGERY AND ANTIRESORPTIVE TREATMENT
Sanchez, EL; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5855. 2017
Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience
Garcia-Robles, AA; (...); Fernandez-Navarro, JM
Meeting Abstract. 2017
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
CAPILLAROSCOPY: A USEFUL TOOL FOR IDENTIFYING PRIMARY RAYNAUD
Martinez Cordellat, I.; (...); Roman Ivorra, J. A.
Article. 10.1136/annrheumdis-2014-eular.4985. 2014
Cardiovascular Risk Assessment with Carotid Ultrasonography in Addition to the Traditional Cardiovascular Risk Factor in Rheumatoid Arthritis: A Case Control Study
Mazario, RG; (...); Ivorra, JAR
Meeting Abstract. 2020
CARDIOVASCULAR RISK ASSESSMENT WITH CAROTID ULTRASONOGRAPHY IN ADDITION TO THE TRADITIONAL CARDIOVASCULAR RISK FACTORS IN RHEUMATOID ARTHRITIS PATIENTS: A CASE CONTROL STUDY
Mazario, RG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6420. 2020
Cardiovascular risk assessment with carotid ultrasound in rheumatoid arthritis.
González Mazarío R; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2022.01.017. 2022
Casal necklace.
Mansilla-Polo, Miguel, Martin-Torregrosa, Daniel, Botella-Estrada, Rafael
Article. 10.1016/j.medcli.2023.03.035. 2023
Clinical and molecular characterization of Wilson's disease in the Valencian Region
Sanchez-Monteagudo, A; (...); Espinos, C
Meeting Abstract. 2018
CLINICAL AND SEROLOGICAL EVOLUTION OF RHEUMATIC PATIENTS INFECTED BY SARS-COV-2
Navarro, M. De la Rubia; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4559. 2022
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical evaluation of rituximab treatment for neuromyelitis optica
Fernández-Megía MJ; (...); Poveda-Andrés JL
Article. 10.1016/j.nrl.2014.09.001. 2015
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Sanmartin, O; (...); Gravalos, C
Article. 10.1016/j.ad.2019.01.011. 2019
Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
Gravalos, C; (...); Botella, R
Article. 10.1007/s12094-018-1953-x. 2019
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
Clinical Practice Guideline on Melanoma From the Spanish Academy of Dermatology and Venereology (AEDV).
Botella-Estrada R; (...); García-Doval I
Article. 10.1016/j.ad.2020.07.003. 2021
Clinical trials: their contribution to the efficiency of the clinical management of rheumatoid arthritis.
Escandell CPA, Ivorra JAR
Article. 10.7573/dic.212612. 2019
CLINICAL VARIABILITY IN PATIENTS DIAGNOSED OF JUVENILE IDIOPATHIC ARTHRITIS WITH POSITIVE AND NEGATIVE ANTINUCLEAR ANTIBODIES (ANA)
Torrat Noves, A. M.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.5203. 2023
Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease.
Bonanad, C; (...); Botella-Estrada, R
Article. 10.1016/j.ad.2016.12.023. 2017
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF-alpha inhibitors.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007. 2023
Collaborative model of home delivery program in haemophilia through an association of patients
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Coma blisters. A key to neurological diagnosis.
Torres-Navarro I; (...); Botella-Estrada R
Letter. 10.1016/j.nrl.2018.11.005. 2020
Comment on 'Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East': pernio unrelated to COVID-19
Torres-Navarro, I; (...); Evole-Buselli, M
Letter. 10.1111/ced.14255. 2020
COMORBIDITY CLUSTERS AND THEIR RELATIONSHIP WITH SEVERITY AND OUTCOMES OF THE INDEX DISEASES, IN A LARGE MULTICENTER SYSTEMIC LUPUS ERYTHEMATOSUS COHORT (RELESSER REGISTER)
Rua-Figueroa, I.; (...); Pego-Reigosa, J. M.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4168. 2023
Comparison between Tocilizumab Prescribed As Monotherapy Versus Combined with Conventional Immunosuppressant Agents in Giant Cell Arteritis Patients
Goercke, MC; (...); Blanco, R
Meeting Abstract. 2018
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practice
Bykerk, VP; (...); Sibilia, J
Article. 10.1007/s10067-014-2857-y. 2015
Complete response of a locally advanced basosquamous carcinoma with vismodegib treatment
Sahuquillo-Torralba, A; (...); Botella-Estrada, R
Letter. 10.4103/ijdvl.IJDVL_647_18. 2019
Complications Associated with Mohs Micrographic Surgery: Data from the Nationwide Prospective Cohort REGESMOHS
Ruiz-Salas, Veronica; (...); Garcia-Doval, Ignacio
Article. 10.1159/000517010. 2021
COMPUTER TOMOGRAPHY GUIDED BIOPSY YIELD IN PYOGENIC VERTEBRAL OSTEOMYELITIS. AN EXAMINATION OF INFLUENCING FACTORS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6627. 2019
Concordance Between the QuantiFERON-TB Gold In-Tube and Tuberculin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Rheumatic Diseases
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 2020
CONCORDANCE BETWEEN THE QUANTIFERON-TB GOLD IN-TUBE AND TUBERCULIN TEST FOR THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION IN PATIENTS WITH RHEUMATIC DISEASES
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.3157. 2021
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Contact dermatitis by face mask.
Mansilla-Polo M, Navarro-Mira MÁ, Botella-Estrada R
Article. 10.1016/j.medcli.2023.01.004. 2023
CONTRIBUTION OF CLINICAL TRIALS TO THE EFFICIENCY OF ARTHRITIS RHEUMATOID MANAGEMENT
Escandell, CA; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.6082. 2017
Correction: 'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.
Mansilla-Polo M; (...); Botella-Estrada R
Correction. 10.1007/s15010-024-02259-0. 2024
CORRELATION BETWEEN PATIENT-REPORTED OUTCOMES OF HEALTH-RELATED QUALITY OF LIFE AND CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5661. 2019
Correlation of Histologic Regression in Primary Melanoma With Sentinel Node Status
Botella-Estrada R; (...); Nagore E
Article. 10.1001/jamadermatol.2013.9856. 2014
Corrigendum to "Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients" [Clin. Biomech. volume 68 (2019) Pages 169-174/Article Number JCLB 4795].
Olmos CMF; (...); Ivorra JAR
Correction. 10.1016/j.clinbiomech.2019.10.023. 2020
Cost analysis of biologic drugs in rheumatoid arthritis first line treatment aftermethotrexate failure according to patients' body weight
Roman Ivorra JA; (...); Gomez-Barrera M
Article. 10.1016/j.reuma.2015.07.008. 2016
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1080/13696998.2017.1311903. 2017
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Trillo, JL; (...); Torres, C
Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
COVID-19 AND JAKI: ANALYSIS AFTER THREE-YEAR PANDEMIC AT A SPANISH TERTIARY CARE HOSPITAL
Munoz Martinez, P.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4263. 2023
Cranial and extracranial giant cell arteritis do not exhibit differences in the IL6 -174 G/C gene polymorphism.
Genre, F.; (...); Gonzalez-Gay, M. A.
Article. 10.55563/clinexprheumatol/cbjnmo. 2023
Cranial and extracranial giant cell arteritis share similar HLA-DRB1 association
Prieto-Pena, D; (...); Gonzalez-Gay, MA
Article. 10.1016/j.semarthrit.2020.07.004. 2020
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
CT GUIDED NEEDLE BIOPSY IN VERTEBRAL OSTEOMYELITIS: RELIABILITY ANALYSIS AND STUDY OF WHICH FACTORS COULD INFLUENCE ON THE RESULT
Fragio-Gil, J. J.; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6383. 2020
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield.
Fragío Gil JJ; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2020.08.007. 2022
CT-Guided Needle Biopsy in Vertebral Osteomyelitis: Study of Factors That Could Influence in Culture Yield
Fragio Gil, Jorge Juan; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2020.08.002. 2022
Current Status of Multidisciplinary Care in Psoriatic Arthritis in Spain: NEXUS 2.0 Project.
Queiro R; (...); Gratacos J
Article. 10.1016/j.reuma.2018.01.010. 2020
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.
Garrido-Jareño M; (...); Pemán-García J
Article. 10.1186/s13071-020-3901-1. 2020
Cutaneous larva migrans.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1016/j.medcli.2023.03.037. 2023
Cutaneous sarcoidosis after platelet-rich plasma injections and permanent eyebrow make-up.
Torregrosa DM; (...); Estrada RB
Case Reports. 10.1016/j.ad.2023.06.023. 2024
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm Registry.
Ruiz-Genao DP; (...); García-Doval I
Article. 10.1016/j.ad.2020.05.008. 2020
Chikungunya fever with a positive tourniquet test: a novel description.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1093/ced/llae089. 2024
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
DECREASE IN THE TEMPORARY WORK INCAPACITY DUE TO MUSCULOSKELETIC DISEASES: UTILITY OF A PREVENTIVE PROGRAM IN VALENCIA-LA FE HEALTH AREA
Rodriguez, JEO; (...); Rheumatology Serv
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5486. 2017
Decreased DNA hydroxymethylation and increased DNA demethylation are associated with high antioxidant response in systemic lupus erythematosus patients.
Fragío Gil JJ; (...); Román Ivorra JA
Case Reports. 10.1016/j.medcli.2020.10.023. 2021
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
Blade, J; (...); Lizan, L
Article. 10.1136/bmjopen-2017-018850. 2018
Delusional parasitosis (Ekbom's syndrome).
Mansilla-Polo, M, Martin-Torregrosa, D, Botella-Estrada, R
Article. 10.1016/j.semerg.2024.102423. 2024
Dermatologic Consultations for Patients Hospitalized in Non-Dermatologic Wards: Results of a 384-Patient Cross-Sectional Study From a Tertiary Referral Hospital
Mansilla-Polo, M.; (...); Botella-Estrada, R.
Letter. 10.1016/j.ad.2024.10.030. 2024
Dermatologic consultations for patients hospitalized in non-dermatologic wards: results of a 384-patient cross-sectional study from a tertiary referral hospital.
Mansilla-Polo, M; (...); Botella-Estrada, R
Case Reports. 10.1016/j.ad.2023.11.021. 2023
Dermatological toxicities of talquetamab, a new bispecific antibody: case series and literature review.
Mansilla-Polo M; (...); Botella-Estrada R
Letter. 10.1111/ddg.15502. 2024
Dermatological toxicities of talquetamab, a new bispecificantibody: case series and literature review
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Letter. 10.1111/ddg.15502_g. 2024
Dermatomyositis panniculitis: A case series and review of the literature
Calle, A; (...); Santos-Briz, A
Meeting Abstract. 2018
Dermoscopic Findings in Trichoblastoma.
Pitarch G, Botella-Estrada R
Article. 10.1016/j.ad.2015.01.017. 2015
Dermoscopy margin delineation in radiotherapy planning for superficial or nodular basal cell carcinoma
Ballester Sánchez R; (...); Botella Estrada R
Letter. 10.1111/bjd.13402. 2015
Dermoscopy of adamantinoid trichoblastoma
Pitarch, G, Botella-Estrada, R
Letter. 10.1111/jdv.12752. 2016
Design and implementation of a custom targeted next-generation sequencing panel in a series of primary melanomas
De Unamuno, B; (...); Botella, R
Meeting Abstract. 2017
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and validation of a model to predict complex Mohs Micrographic Surgery in clinical practice: REGESMOSH scale.
Montero-Vilchez, Trinidad R.; (...); Sanmartin-Jimenez, Onofre
Article. 10.1111/jdv.19056. 2023
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology.
Urruticoechea-Arana A; (...); Rúa-Figueroa Í
Article. 10.1016/j.reuma.2019.09.001. 2019
Development of psoriasis in a patient with reumatoid arthritis after rituximab
Olmos, CMF; (...); Ivorra, JAR
Letter. 10.1016/j.medcli.2013.01.024. 2014
Diagnosis of Giant Cell Arteritis in Spain: Data from the ARTESER Registry
De Miguel, Eugenio; (...); Blanco, Ricardo
Meeting Abstract. 2021
Diagnosis of Lung Cancer Due to a Complicated Abscess.
Torres-Navarro I, Piqueras-García J, Botella-Estrada R
Editorial Material. 10.1016/j.ad.2018.01.020. 2019
DIFFERENCES IN BONE METABOLISM BETWEEN INTERMITTENT AND CONTINUOUS TREATMENT WITH LHRH AGONISTS IN PROSTATE CANCER PATIENTS
Arevalo, KR; (...); Roman, JA
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6948. 2018
Differences in BONE Metabolism between Intermittent and Continuous Treatment with LHRH Agonists in Prostate Cancer Patients
Ruales, KA; (...); Ivorra, JAR
Meeting Abstract. 2017
Divided or kissing nevus of the penis: A new case with dermoscopic findings
Armengot-Carbo, M, Rodrigo-Nicolas, B, Botella-Estrada, R
Article. 10.1111/pde.13556. 2018
DNA Copy Number Variation Associated with Anti-tumour Necrosis Factor Drug Response and Paradoxical Psoriasiform Reactions in Patients with Moderate-to-severe Psoriasis
Sanz-Garcia, A; (...); Ovejero-Benito, MC
Article. 10.2340/00015555-3794. 2021
DNA HYPOMETHYLATION AND DECREASED HYDROXYMETHYLATION IS ASSOCIATED WITH DECREASED ANTIOXIDANT RESPONSE IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS
Garcia, EG; (...); Lvorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.2905. 2017
Does hyaluronidase injected in periocular area change skin ultrastructure?: Standardized in vitro analysis
Aguilar-González M; (...); Pérez-López M
Article. 10.1111/jocd.15014. 2022
Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.
Pérez Huertas P; (...); Poveda Andrés JL
Article. 10.7399/fh.2015.39.4.8839. 2015
Dose tapering of dupilumab in patients with persistently controlled atopic dermatitis: a Spanish multicenter cohort study
Lasheras-Pérez MA; (...); Rodríguez-Serna M
Article. 10.1111/ijd.17030. 2024
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP).
Rodriguez, C Couselo; (...); Florez, A.
Article. 10.1016/j.ad.2023.07.014. 2023
Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases
Megias-Vericat, JE; (...); Poveda, JL
Review. 10.1007/s10072-017-2833-9. 2017
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan
Ribera, E; (...); Hernandez-Novoa, B
Article. 10.1016/j.eimc.2016.11.015. 2018
Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases.
de la Rubia Navarro, Marta; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.05.003. 2022
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
Effect of different schemes of androgen deprivation therapy on bone mass density in prostate cancer patients.
Arevalo Ruales, Karla; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.medcli.2022.03.026. 2023
Effect of Sex in Systemic Psoriasis Therapy: Differences in Prescription, Effectiveness and Safety in the BIOBADADERM Prospective Cohort
Hernandez-Fernandez, CP; (...); Garcia-Doval, I
Article. 10.2340/00015555-3711. 2021
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish population.
Sahuquillo-Torralba, A; (...); Botella-Estrada, R
Article. 10.1111/ajd.14130. 2023
Effectiveness in the treatment of solar urticaria with omalizumab: Report of 7 cases
Sahuquillo-Torralba, A, Rodriguez-Serna, M, Botella Estrada R
Letter. 10.1016/j.medcli.2018.01.003. 2018
EFFECTIVENESS OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS OF A MULTICENTER SPANISH COHORT
Altabas Gonzalez, I.; (...); Rua-Figueroa, I.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3482. 2023
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Effectiveness of Tocilizumab in Cranial and Extracranial Phenotypes of Giant Cell Arteritis: Multicenter Study of 471 Cases
Sanchez-Bilbao, Lara; (...); Blanco, Ricardo
Meeting Abstract. 2021
Effectiveness of Tocilizumab in the Visual Involvement of Giant Cell Arteritis: Multicenter Study of 471 Patients of Clinical Practice
Sanchez-Bilbao, Lara; (...); Blanco, Ricardo
Meeting Abstract. 2021
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice.
Mansilla-Polo M; (...); Botella-Estrada R
Letter. 10.1111/ajd.14151. 2023
EFFICACY AND SAFETY OF APREMILAST IN BEHCET DISEASE PATIENTS
Bernabeu, EV; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.5330. 2020
EFFICACY AND SAFETY OF BARICITINIB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: DATA FROM REAL-WORLD
Mazario, RG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6321. 2020
Efficacy and safety of electronic brachytherapy for superficial and nodular basal cell carcinoma
Ballester-Sánchez R; (...); Perez-Calatayud J
Article. 10.5114/jcb.2015.52140. 2015
Efficacy of Raynaud's phenomenon and digital ulcer pharmacological treatment in systemic sclerosis patients: a systematic literature review
Lefebvre, PGD; (...); Munoz-Fernandez, S
Review. 10.1007/s00296-015-3241-1. 2015
Efficacy of Tocilizumab in Giant Cell Arteritis, Independent of the Time of Disease Evolution
Calderon-Goercke, Monica; (...); Blanco, Ricardo
Meeting Abstract. 2019
Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study
Pablos, JL; (...); Rivero, N
Article. 2019
eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Megias-Vericat, JE
Meeting Abstract. 2018
Electronic brachytherapy for superficial and nodular basal cell carcinoma: a report of two prospective pilot trials using different doses
Ballester-Sanchez, R; (...); Botella-Estrada, R
Article. 10.5114/jcb.2016.57531. 2016
Eosinophilic follicular reaction induced by Demodex folliculorum mite: a different disease from eosinophilic folliculitis
Sabater-Marco V, Escutia-Muñoz B, Botella-Estrada R
Article. 10.1111/ced.12566. 2015
Eosinophilic Granulomatosis with Polyangiitis: Clinical Suspicion Red Flags Identification by a Systematic Literature Review and Multidisciplinary Expert Consensus
Blanco, Ricardo; (...); Alvaro-Gracias, Jose Maria
Meeting Abstract. 2023
EPIDEMIOLOGY, DIAGNOSIS AND CLINICAL CHARACTERISTICS OF GIANT CELL ARTERITIS IN PATIENTS INCLUDED IN THE ARTESER MULTICENTER STUDY
Sanchez-Costa, J. T.; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.1313. 2022
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
Vizoso M; (...); Esteller M
Article. 10.1038/nm.3863. 2015
Erfolgreiche Imatinib-Therapie einer mit dem myeloproliferativen hypereosinophilen Syndrom mit PDGFRA-Rearrangement assoziierten lymphomatoiden Papulose
Torres-Navarro I; (...); Botella-Estrada R
Letter. 10.1111/ddg.14064_g. 2020
Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.
Pablos JL; (...); Rivero N
Correction. 2020
Erythema Elevatum Diutinum.
Mansilla-Polo M, Botella-Estrada R
Article. 10.1016/j.ad.2023.10.042. 2024
Erythemato-violaceous plaques on the shin of a trasplanted lung host.
Sahuquillo-Torralba A; (...); Botella-Estrada R
Article. 10.1016/j.medcli.2017.05.024. 2017
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
EVALUATION OF CUMULATIVE DAMAGE IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AS A NEW CARDIOVASCULAR RISK FACTOR
Fernandez Matilla, M.; (...); Roman Ivorra, J.
Meeting Abstract. 10.1136/annrheumdis-2016-eular.4119. 2016
Evaluation of the impact of nursing clinics in the rheumatology services
Munoz-Fernandez, S; (...); Lazaro, P
Article. 10.1007/s00296-016-3518-z. 2016
EXPERIENCE IN REAL-WORLD CONDITIONS OF THE EFFECTIVENESS OFTHEVACCINE AGAINST HERPES ZOSTER
Mas Sanchez, L.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4258. 2023
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
Experience of Home Delivery Program in Haemophilia Through an Association of Patients
Megias Vericat, J. E.; (...); Bonanad Boix, S.
Meeting Abstract. 2017
Expert Recommendations on the Interleukin 6 Blockade in Patients with Rheumatoid Arthritis.
Tornero Molina, Jesus; (...); Sanmarti, Raimon
Article. 10.1016/j.reuma.2018.07.004. 2018
EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY
Paz S; (...); Urcelay J
Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
Albert-Mari, A; (...); Poveda-Andres, JL
Article. 10.1007/s11096-018-0714-9. 2018
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
Fatal outcome in classic Kaposi's sarcoma.
Mansilla-Polo M, Botella-Estrada R
Article. 10.1016/j.ad.2023.03.013. 2024
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
Folliculitis Decalvans Caused by Bacterial Superinfection Secondary to Erlotinib.
Sahuquillo-Torralba, A; (...); Botella-Estrada, R
Letter. 10.1016/j.ad.2017.02.032. 2018
Folliculotropic Mycosis Fungoides With Flexural Eruptive Cysts and Comedones in a 14-Year-Old Boy.
Roca-Gines, J; (...); Botella-Estrada, R
Article. 10.1097/DAD.0000000000001958. 2021
FREQUENCY OF POLYAUTOIMMUNITY IN A TERTIARY HOSPITAL
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5582. 2019
Generalized non-evanescents wheals with targetoid purpuric plaques.
Sahuquillo-Torralba A; (...); Botella-Estrada R
Article. 10.1016/j.medcli.2017.10.006. 2018
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Genotype FBN1/Phenotype relationship in a cohort of patients with Marfan syndrome.
Hernándiz A; (...); Sepúlveda P
Article. 10.1111/cge.13879. 2020
Giant Cell Arteritis Subtypes: Data from the ARTESER Registry
De Miguel, Eugenio; (...); Blanco, Ricardo
Meeting Abstract. 2021
Giant Cell Arteritis-Polymyalgia Rheumatica Spectrum Disease: Relation with Neoplasms and Role as a Paraneoplastic Syndrome
Munoz Martinez, Pablo; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Guselkumab, Risankizumab, and Tildrakizumab demonstrate parallel effectiveness and safety in psoriasis treatment: a head-to-head comparative study in real clinical practice.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1016/j.abd.2024.04.004. 2024
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Lopez-Isac, E; (...); ASIG
Article. 10.1038/s41467-019-12760-y. 2019
Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12568. 2017
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units
Article. 10.7399/fh.10935. 2018
Hazardous drugs: new challenges, new opportunities.
Valero García S; (...); Poveda Andrés JL
Article. 10.7399/fh.2016.40.2.10462. 2016
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports
Ivorra, JAR; (...); Vivas-Consuelo, D
Article. 10.1007/s10067-019-04485-6. 2019
HEALTH-RELATED QUALITY OF LIFE MEASURES IN SPONDYLOARTHROPATY PATIENTS UNDER BIOLOGICAL THERAPIES IN REAL LIFE
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2021-eular.2282. 2021
Hemihypoatrophy as an extraordinary manifestation of linear morphoea.
Mansilla-Polo, Miguel, Navarro-Mira, Miguel A., Botella-Estrada, Rafael
Article. 10.1093/rap/rkac104. 2022
Herpes vegetans of the vulva.
Abril-Pérez C; (...); Botella-Estrada R
Article. 10.1016/j.ajog.2021.05.024. 2021
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
HIGH LEVELS OF ANTI-U1RNP AND ANTI-SM IN MIXED CONNECTIVE TISSUE DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6402. 2018
Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence.
Verdaguer-Faja, Julia; (...); Jaka, Ane
Article. 10.1111/jdv.20250. 2024
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
Hyperparathyroidism in patients with low bone mineral density treated with zoledronic acid or denosumab.
Riesco-Bárcena C; (...); Román-Ivorra J
Article. 10.1016/j.medcli.2024.07.020. 2024
Identification of c.104T>G, p.Met35Arg (NM_00314.8) variant in heterozygosity in exon 2 of the PTEN gene as the Causative Factor for Cowden Syndrome: A Medical Case Study.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1093/ced/llad344. 2023
IL2 DECREASE AND INCREASE OF IL10 AND INF1A ARE ASSOCIATED TO CLINICAL ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOUSPATIENTS
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6747. 2018
IL2 Decrease Is Associated to ANTI-DNA Positivity in Systemic LUPUS Erythematous Patients
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 2018
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2016.1231405. 2017
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis
Edo Solsona MD; (...); Poveda Andrés JL
Article. 10.2147/PPA.S127508. 2017
IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS
Edo-Solsona, M.; (...); Poveda-Andres, J.
Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016
Impact of an antimicrobial stewardship program on critical haematological patients.
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.7399/fh.2017.41.4.10709. 2017
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
IMPACT OF GENDER IN JAK INHIBITORS PRESCRIPTION: ANALYSIS FROM A SINGLE CENTER COHORT
Garcia, E. Grau; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3917. 2022
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1038/tpj.2017.19. 2018
Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1097/FPC.0000000000000286. 2017
Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation
Ruiz J; (...); Aliño SF
Article. 10.3390/ijms160920168. 2015
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
IMPLEMENTATION OF A WEEKLY CONSULTATION OF EMERGENCY ROOM PATIENTS IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES
Roman Ivorra, J. A.; (...); Ivorra Cortes, J.
Article. 10.1136/annrheumdis-2014-eular.5020. 2014
Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1159/000478969. 2018
Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register.
Fernandez-Lozano, Delia; (...); Blanco, Ricardo
Article. 10.1136/rmdopen-2023-003824. 2024
Incidence and General Clinical Features of Giant Cell Arteritis in the ARTESER Multicenter Study
Sanchez-Costa, Jesus T.; (...); Blanco, Ricardo
Meeting Abstract. 2021
Incidence of Hyperparathyroidism in Patients with Osteoporosis Treated with Zoledronic Acid or Denosumab
Riesco Barcena, Carmen; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: a Biobadaderm cohort analysis.
Baniandrés-Rodríguez O; (...); García-Doval I
Letter. 10.1016/j.jaad.2020.10.046. 2021
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Incomplete Mohs surgery: a long-term, nationwide prospective cohort to describe recurrence rate and risk factors (REGESMOHS, Spanish Registry of Mohs Surgery).
Oro-Ayude, M.; (...); REGESMOHS (Registro Español de Cirugía de Mohs)
Letter. 10.1111/jdv.17597. 2022
Increase of IL10 and IFNa2 Are Associated to Clinical Activity in Systemic Lupus Erythematous Patients
Grau Garcia, Elena; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Increased interferon-1a, interleukin-10 and BLyS concentrations as clinical activity biomarkers in systemic lupus erythematosus.
Fernández Matilla M; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2018.12.012. 2019
INCREASED LEVELS OF INTERFERON ALPHA AND INTERLEUKIN-10 AS CLINICAL ACTIVITY BIOMARKERS IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.4180. 2017
Indeterminate Cell Histiocytosis in Children: A Case Report.
Sahuquillo-Torralba, A.; (...); Botella-Estrada, R.
Letter. 10.1016/j.ad.2017.01.022. 2017
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables
Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago
Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016
Infectious pubic plaque.
Torres-Navarro, Ignacio; (...); Botella-Estrada, Rafael
Editorial Material. 10.1016/j.eimc.2019.03.004. 2019
INFECTIOUS SPONDYLODISCITIS: 7-YEAR ANALYSIS OF CLINICAL AND PROGNOSTIC VARIABLES IN A TERTIARY HOSPITAL
Fragio, J; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2018-eular.7272. 2018
Inflammatory tinea manuum: The importance of pustules.
Sahuquillo Torralba A, Navarro Mira MÁ, Botella Estrada R
Article. 10.1016/j.medcli.2016.10.020. 2017
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
Megías-Vericat JE; (...); Aliño SF
Review. 10.1038/tpj.2014.80. 2015
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2017.1323267. 2017
Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.
Ruiz J; (...); Poveda JL
Article. 10.23736/S0026-4946.18.04978-2. 2018
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Meeting Abstract. 2015
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register
De Miguel, Eugenio; (...); Blanco, Ricardo
Article. 10.1136/rmdopen-2022-002507. 2022
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register (vol 8, e002507, 2022)
De Miguel, Eugenio; (...); Blanco, Ricardo
Correction. 10.1136/rmdopen-2022-002507corr1. 2023
Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.
Bermejo San José F; (...); Sanromán-Álvarez L
Article. 10.7399/fh.2016.40.5.10180. 2016
Interim analysis of the multinational, post-authorization safety study (NISSO) to assess the long-term safety of sonidegib in patients with locally advanced basal cell carcinoma
Gutzmer, Ralf; (...); Hauschild, Axel
Article. 10.1186/s12885-024-13101-z. 2024
Interparietal nodule in a 49-year-old woman.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Case Reports. 10.1111/ddg.15398. 2024
Interparietaler Knoten bei einer 49-jährigen Frau
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15398_g. 2024
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
Is Belimumab Dose Optimization Possible in Patients with Systemic Lupus Erythematosus?: Analysis of This Therapeutic Strategy in a Large Multicenter Cohort of Patients from Spanish Rheumatology Departments
Altabas Gonzalez, Irene; (...); Rua-Figueroa, Inigo
Meeting Abstract. 2023
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
JAK inhibitors in combination with anti-TNF drugs on difficult-to-treat chronic polyarthritis: a case series.
Leal S; (...); Román-Ivorra JA
Letter. 10.55563/clinexprheumatol/4ao14k. 2024
Kidney Disease and Psoriasis. A New Comorbidity?
González-Parra E; (...); Rivera R
Article. 10.1016/j.ad.2016.05.009. 2016
Klinisch-pathologische Eigenschaften kutaner und mukokutaner Leishmaniose bei mit TNF-a-Inhibitoren behandelten Patienten.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.1111/ddg.15007_g. 2023
Label-free piezoelectric biosensor for prognosis and diagnosis of Systemic Lupus Erythematosus
do Nascimento NM; (...); Gimenez-Romero D
Article. 10.1016/j.bios.2016.11.004. 2017
Lack of TERT promoter mutations in melanomas with extensive regression
De Unamuno Bustos B; (...); Botella Estrada R
Letter. 10.1016/j.jaad.2015.10.003. 2016
LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.
Castellví I; (...); Fonollosa V
Article. 10.1007/s00296-019-04436-z. 2019
LENGTHENING OF RECOMMENDED DOSE RANGE OF ANTI-TNF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PERIPHERAL PSORIATIC ARTHRITIS IN REMISSION
Cornejo Piquer, C. Nunez; (...); Roman Lvorra, J. A.
Article. 10.1136/annrheumdis-2014-eular.4944. 2014
Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF(V600R) mutation
Sabater-Marco V; (...); Botella-Estrada R
Letter. 10.1111/jdv.13118. 2016
'Lesion on the back of the hand in a hematopoietic stem cell transplant recipient'.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1007/s15010-024-02214-z. 2024
LONG-TERM FOLLOW-UP OF 214 PRIMARY RAYNAUD' S PHENOMENON PATIENTS
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2018-eular.6318. 2018
LONG-TERM FOLLOW-UP OF PRIMARY RAYNAUD'S PHENOMENON COHORT OF 248 PATIENTS
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5989. 2019
Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
Bykerk VP; (...); Sibilia J
Article. 10.1007/s10067-019-04535-z. 2019
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
Dauden, E; (...); Garcia-Doval, I
Article. 10.1016/j.jaad.2020.03.033. 2020
LUPUS NEPHRITIS RESPONSE IN TERMS OF KIDNEY FUNCTION, URINE SEDIMENT AND SEROLOGICAL ACTIVITY AFTER SUBCUTANEOUS BELIMUMAB TREATMENT
De la Rubia Navarro, M.; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2944. 2022
Lymph Node Dissection in Patients with Melanoma and Sentinel Lymph Node Metastasis: An Updated, Evidence-Based Decision Algorithm
Moreno-Ramirez, D; (...); Academia Espanola Dermatologia Ven
Article. 10.1016/j.ad.2018.02.008. 2018
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Melanoma and LEOPARD Syndrome: Understanding the Role of PTPN11 Mutations in Melanomagenesis.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Article. 10.2340/actadv.v104.14720. 2024
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Methotrexate in patients with rheumatoid arthritis in Spain: Subanalysis of the AR Excellence project.
Tornero-Molina J; (...); Sanchez-Alonso F
Article. 10.1016/j.reuma.2017.11.007. 2019
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
Murria Estal, Rosa; (...); Botella Estrada, Rafael
Article. 10.1097/CMR.0000000000000709. 2020
Migratory arthralgia as the initial sign of systemic toxicity associated with chronic nitrofurantoin treatment.
Arevalo Ruales, Karla; (...); Martinez Frances, Manuela
Letter. 10.1016/j.reuma.2018.07.006. 2018
MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.
Tarazon, Estefania; (...); Botella Estrada, Rafael
Article. 10.3390/genes12121931. 2021
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry Experience.
Nieto Benito LM; (...); García-Doval I
Case Reports. 10.1016/j.ad.2021.05.017. 2022
Mohs micrographic surgery in dermatofibrosarcoma protuberans: Rate and risk factors for recurrence in a prospective cohort study from the Spanish Registry of Mohs Surgery (REGESMOHS) and review of the literature.
Nieto-Benito LM; (...); Garcia-Doval I
Review. 10.1111/exd.14291. 2021
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery).
Abril-Pérez C; (...); Botella-Estrada R
Article. 10.1111/jdv.20103. 2024
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.
Fernandez-Megia, MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.10793. 2018
MORPHOLOGICAL CHARACTERIZATION OF THE CUTANEOUS BIOPSIES IN THE EICH: INFLAMMATORY INFILTRATION STUDY AND THE EXPRESSION OF ELAFIN
Moles Poveda, P.; (...); Sanz Caballer, J.
Meeting Abstract. 2018
Mortality in Patients with Giant Cell Arteritis in Spain: Results from the ARTESER Registry
Molina-Collada, Juan; (...); Blanco-Alonso, Ricardo
Meeting Abstract. 2024
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry
Molina-Collada, Juan; (...); ARTESER Project Collaborative Grp, Clara
Article. 10.1186/s13075-024-03468-6. 2025
Mucosal melanoma: an update.
Ballester Sánchez R; (...); Botella Estrada R
Article. 10.1016/j.ad.2014.04.012. 2015
Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus
Rua-Figueroa, Inigo; (...); Calvo Alen, Jaime
Article. 10.1016/j.reuma.2024.03.005. 2024
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
Multiple pilomatricomas in a child with xeroderma pigmentosum: Coincidence or association?
Palacios-Diaz RD; (...); Botella-Estrada R
Article. 10.1111/pde.14924. 2022
Multiple Primary Melanomas: Retrospective Review in a Tertiary Care Hospital
Palacios-Diaz RD; (...); Botella-Estrada R
Article. 10.3390/jcm11092355. 2022
Musculoskeletal Manifestations in Patients Diagnosed with Marfan Syndrome
Mas Sanchez, Laura; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM
Climente Martí M, Poveda Andrés JL, Culebras J
Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015
Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.
Mansilla-Polo M, Escutia-Muñoz B, Botella-Estrada R
Article. 10.1016/j.ad.2023.08.001. 2023
Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future.
Mansilla-Polo, M., Escutia-Munoz, B., Botella-Estrada, R.
Article. 10.1016/j.ad.2023.05.015. 2023
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New alpha-papillomavirus 4 isolate in a verruca vulgaris with multicentric superficial basal cell carcinoma
Sabater-Marco V; (...); Botella-Estrada R
Letter. 10.1111/ijd.12749. 2015
New a-papillomavirus 4 isolate in a verruca vulgaris with multicentric superficial basal cell carcinoma.
Sabater-Marco V; (...); Botella-Estrada R
Article. 2015
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
New structural insights into the role of TROVE2 complexes in the on-set and pathogenesis of systemic lupus erythematosus determined by a combination of QCM-D and DPI.
Juste-Dolz A; (...); Maquieira Á
Article. 10.1007/s00216-018-1407-x. 2019
Nodular hidradenoma: Case report and brief literature review.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1016/j.patol.2025.100801. 2025
Non-adherence to subcutaneous biological medication in patients with rheumatoid arthritis: a multicentre, non-interventional study
Calvo-Alen, J; (...); Marras, C
Article. 2017
Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes
Tormo A; (...); Perez-Calatayud J
Article. 10.5114/jcb.2014.43247. 2014
Novel Blood Biomarkers for Response Prediction and Monitoring of Stereotactic Ablative Radiotherapy and Immunotherapy in Metastatic Oligoprogressive Lung Cancer.
Zafra J; (...); Barragán I
Article. 10.3390/ijms25084533. 2024
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Poveda, JL
Meeting Abstract. 2018
Optimization of Tocilizumab Therapy in Giant Cell Arteritis: A Multicenter Real Life Study of 134 Patients
Calderon-Goercke, Monica; (...); Blanco, Ricardo
Meeting Abstract. 2019
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Oral Ruxolitinib could Increase the Aggressiveness of Cutaneous Squamous Cell Carcinomas: A 6-Patient Series
Lasheras-Perez, M. A.; (...); Botella-Estrada, R.
Letter. 10.1016/j.ad.2023.07.035. 2025
OXIDATIVE STRESS LEVELS ARE INCREASED IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH A HIGHER ACCUMULATIVE DAMAGE SCORE
Grau Garcia, E.; (...); Roman Ivorra, J.
Meeting Abstract. 10.1136/annrheumdis-2016-eular.3183. 2016
Pancreatic panniculitis.
Torres-Navarro I, Rojas-Ferrer N, Botella-Estrada R
Article. 10.17235/reed.2019.6116/2018. 2019
Papulonecrotic tuberculides as a key to the diagnosis of tuberculosis: a case report.
Mansilla-Polo M; (...); Botella-Estrada R
Letter. 10.1111/ijd.16940. 2024
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Paradoxical psoriasiform reactions by anti-TNF treated with Ustekinumab in patients with inflammatory bowel disease
Sahuquillo-Torralba, A; (...); Botella-Estrada, R
Meeting Abstract. 2019
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Patient Decision Aid (PDA) for Patients with Rheumatoid Arthritis Reduces Decisional Conflict and Improves Readiness for Treatment Decision Making.
Pablos JL; (...); Lizán L
Article. 10.1007/s40271-019-00381-y. 2020
Patients with primary cutaneous lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry.
Sánchez-Velázquez A; (...); Ortiz-Romero PL
Letter. 10.1111/jdv.17430. 2021
Pembrolizumab: a new Drug That Can Induce Exacerbations of Psoriasis.
Sahuquillo-Torralba A; (...); Botella-Estrada R
Letter. 10.1016/j.ad.2015.07.012. 2016
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.2174/1389200218666171101124931. 2018
Pharmacogenomics and the treatment of acute myeloid leukemia
Megías-Vericat JE; (...); Aliño SF
Review. 10.2217/pgs-2016-0055. 2016
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.
Calleja Hernández MÁ; (...); Aragon, B
Article. 10.7399/fh.2017.41.1.10463. 2017
Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)
Querol-Fuentes, F; (...); Bonanad, S
Meeting Abstract. 2017
Pilot evaluation of home delivery programme in haemophilia
Megias-Vericat, JE; (...); Poveda-Andres, JL
Article. 10.1111/jcpt.12718. 2018
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Pleomorphic cutaneous Rosai-Dorfman disease
Martinez-Ciarpaglini, C; (...); Monteagudo, C
Letter. 10.1111/his.13101. 2017
Podoconiosis.
Mansilla-Polo, Miguel, Lopez-Leon, Paula Teresa, Botella-Estrada, Rafael
Article. 10.1001/jamadermatol.2023.4143. 2023
Points to Consider in the Foundation of Multidisciplinary Units for Psoriatic Arthritis: A Delphi Study and a Systematic Review of the Literature
Gratacos-Masmitja, J; (...); Lopez-Estebaranz, JL
Review. 10.1007/s12325-016-0429-z. 2017
Position statement for the management of comorbidities in psoriasis
Dauden, E; (...); Rivera, R
Article. 10.1111/jdv.15177. 2018
Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis
Megías-Vericat JE; (...); Aliño SF
Letter. 10.1038/tpj.2015.79. 2016
Practice guidelines for the use of subcutaneous abatacept.
Mola EM; (...); Carmona L
Article. 10.1016/j.reuma.2013.11.006. 2014
Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process
Valero, S; (...); Poveda, JL
Article. 10.1016/j.yrtph.2018.03.001. 2018
PREDICTIVE MODEL FOR SHOULDER PAIN USING CLINICAL AND EPIDEMIOLOGICAL VARIABLES
Olmos, CF; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.6010. 2017
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Prevalence and clinical characteristics of patients with rheumatoid arthritis with interstitial lung disease using unstructured healthcare data and machine learning
Román Ivorra JA; (...); Castellanos-Moreira R
Article. 10.1136/rmdopen-2023-003353. 2024
PREVALENCE AND COMORBIDITIES OF RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IN SPAIN: A RETROSPECTIVE ANALYSIS OF ELECTRONIC HEALTH RECORDS USING NATURAL LANGUAGE PROCESSING
Roman Ivorra, J. A.; (...); Lujan Valdes, S.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.5042. 2022
Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study
Sampogna, F.; (...); EPIDEPSO Investigators
Article. 10.1111/bjd.15243. 2017
PREVALENCE OF HEPATITIS B AND C INFECTION AND REACTIVATION IN PATIENTS RECEIVING BIOLOGIC IV THERAPIES
Ruales, KA; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.4827. 2017
PREVALENCE, DIAGNOSTIC DELAY AND TREATMENT PROFILE OF PATIENTS WITH MONOGENIC AUTOINFLAMMATORY DISEASES IN AN ADULT RHEUMATOLOGY SERVICE OF A TERTIARY HOSPITAL.
Perales, C. Pavez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4143. 2022
Primary cutaneous embryonal rhabdomyosarcoma with desmoplastic growth pattern and anaplastic lymphoma kinase overexpression. Report of a case with special emphasis on the differential diagnosis.
Sabater-Marco V; (...); Botella-Estrada R
Letter. 10.1111/ced.13877. 2019
Primary Cutaneous Lymphoma Registry of the Spanish Academy of Dermatology and Venereology (AEDV): Data for the First 5 Years.
Falkenhain-Lopez, D; (...); Ortiz-Romero, P L
Article. 10.1016/j.ad.2022.11.010. 2023
Primary cutaneous lymphomas in children: A prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry.
Torre-Castro J; (...); Machan S
Article. 10.1111/pde.14811. 2021
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
PROFILE OF REAL WORLD AXIAL SPONDYLOARTHRITIS PATIENTS REFRACTORY TO ADVANCED THERAPY
Alcantara Alvarez, I; (...); Roman Ivorra, J. A.
Meeting Abstract. 2024
PROFILE OF REFRACTORY RA PATIENTS FOR TARGETED THERAPIES IN REAL LIFE
Garcia, E. Grau; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2023-eular.4014. 2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study.
Marti-Marti I; (...); Toll A
Article. 10.1016/j.jaad.2023.02.048. 2023
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS
Megias Vericat, J. E.; (...); Sanz, M. A.
Article. 2015
Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability
Shoeibi, A; (...); TAUROS Investigators
Article. 10.1016/j.parkreldis.2019.07.010. 2019
PROSPECTIVE STUDY OF 24 MONTHS OF EVOLUTION OF A COHORT OF PATIENTS WITH RHUPUS
Cordellat, I. Martinez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3898. 2022
PROSPECTIVE STUDY OF BONE METABOLISM AND FRACTURE INCIDENCE IN SPINAL CORD INJURY PATIENTS DURING A PERIOD OF 24 MONTHS
Cordellat, IM; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5953. 2019
Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1097/DSS.0000000000001046. 2017
Pseudogout in a patient with bilateral total knee prosthesis: A challenging diagnosis
Escriva-Fornes, M; (...); Ivorra-Cortes, J
Letter. 10.1016/j.jbspin.2015.05.015. 2016
Pseudoxanthoma Elasticum-Like Papular Eruption
Sabater-Marco, Vicente, Sanz-Motilva, Virginia, Botella-Estrada, Rafael
Article. 10.1097/DAD.0000000000000490. 2017
Psoriasis and Nonalcoholic Fatty Liver Disease.
Carrascosa, JM; (...); Olveira-Martin, A
Article. 10.1016/j.ad.2016.12.017. 2017
Psoriasis onset over a fresh tattoo.
Abril-Perez, Carlos; (...); Botella-Estrada, Rafael
Article. 10.1016/j.medcli.2022.01.014. 2022
PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: 10 YEARS EXPERIENCE.
Ortiz-Sanjuan, F.; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3085. 2022
PULMONARY FUNCTION IN PATIENTS DIAGNOSED OF EARLY SYSTEMIC SCLEROSIS: A NEW TOOL FOR SYSTEMIC SCLEROSIS CLASIFFICATION?
Sanjuan, FMO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.4423. 2020
PULMONARY INVOLVEMENT AND FUNCTIONAL LIMITATION IN SYSTEMIC SCLEROSIS
Rodriguez, JEO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6576. 2019
Pulmonary venous thrombosis secondary to radiofrequency ablation of the pulmonary veins.
Lopez-Reyes, R; (...); Nauffal, D
Article. 10.1016/j.rmcr.2017.11.008. 2018
Pyoderma Gangrenosum With Ulcerative Colitis Successfully Treated With Ustekinumab.
Piqueras-García J; (...); Botella-Estrada R
Letter. 10.1016/j.ad.2018.03.034. 2019
Pyogenic Vertebral Osteomyelitis: Outcome Variables Analysis in a 116 Patients Cohort at a Tertiary Hospital during the Last 8 YEARS
Gil, JJF; (...); Ivorra, JAR
Meeting Abstract. 2018
Quality standards in a rheumatology Day-Care Hospital Unit. The proposal of the Spanish Society of Rheumatology Day Hospitals' Working Group.
Garcia-Vicuna R; (...); Loza E
Article. 10.1016/j.reuma.2014.02.008. 2014
Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker
Perez-Alenda, S; (...); Querol, F
Letter. 10.1111/hae.13388. 2018
Raccoon eyes as a diagnostic key for suspected amyloidosis
Mansilla-Polo, Miguel, Botella-Estrada, Rafael
Editorial Material. 10.1093/rap/rkad105. 2023
Rapidly growing retroarticular tumor: the importance of physical examination
Torres-Navarro, I, Piqueras-Garcia, J, Botella-Estrade, R
Editorial Material. 2018
Rapidly progressive frontal necrotic plaque in an immunosuppressed host
Sahuquillo-Torralba, A; (...); Botella-Estrada, R
Editorial Material. 10.1016/j.eimc.2017.01.003. 2018
Reactive arthritis.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1016/j.medcli.2023.08.017. 2023
REAL LIFE SAFETY AND SURVIVAL OF TARGETED THERAPIES IN ARTHRITIS PATIENTS OVER AGE OF 65
Grau Garcia, E.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.3018. 2023
Real World Data on Antifibrotics in Rheumatoid Arthritis-Interstitial Lung Disease. National Multicenter Study of 73 Patients
Atienza-Mateo, Belen; (...); Blanco, Ricardo
Meeting Abstract. 2023
Real-world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study.
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Article. 10.1111/ajd.14339. 2024
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study
Gonzalez Mazario, Roxana; (...); Roman Ivorra, Jose Andres
Article. 10.1016/j.reuma.2021.08.001. 2022
Real-world Effectiveness and Safety of JAK Inhibitors in Rheumatoid Arthritis: A Single-centre Study.
González Mazarío R; (...); Román Ivorra JA
Article. 10.1016/j.reumae.2021.08.004. 2022
Real-world evidence of tofacitinib in rheumatoid arthritis patients in Spain
Roman Ivorra, Jose A., Llevat, Noelia, Montoro, Maria
Article. 10.5582/ddt.2022.01028. 2022
Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast
Mansilla-Polo, M.; (...); Botella-Estrada, R.
Letter. 10.1016/j.ad.2024.10.025. 2024
Recalcitrant Hailey-Hailey Disease With Satisfactory Response to Apremilast.
Mansilla-Polo, M; (...); Botella-Estrada, R
Case Reports. 10.1016/j.ad.2023.05.022. 2023
Recalcitrant lichen planopilaris treated with upadacitinib: a case series
Lasheras-Perez, Miguel A.; (...); Botella-Estrada, Rafael
Article. 10.1111/ijd.17339. 2024
Recommendations for the use of parenteral methotrexate in rheumatic diseases.
Molina, JT; (...); de Salazar, JRG
Article. 10.1016/j.reuma.2016.12.001. 2018
Red flags for clinical suspicion of eosinophilic granulomatosis with polyangiitis (EGPA).
Solans-Laque, R; (...); Cid, M C
Article. 10.1016/j.ejim.2024.06.008. 2024
Reduced Diffusion Capacity in COVID-19 Survivors.
Mendez, Raul; (...); Menendez, Rosario
Article. 10.1513/AnnalsATS.202011-1452RL. 2021
Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.
Cuéllar Monreal MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.2017.41.1.10434. 2017
Refractory acute graft versus host disease treated with extracorporeal photopheresis
Moles-Poveda, P; (...); Estrada, RB
Meeting Abstract. 2017
Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series.
Martin-Torregrosa, Daniel; (...); Torres-Navarro, Ignacio
Letter. 10.1111/ijd.17022. 2024
Refractory RA Patients for Targeted Therapies in Real Life
Grau Garcia, Elena; (...); Roman Ivorra, Jose Andres
Meeting Abstract. 2023
RELATION BETWEEN ACCUMULATIVE DAMAGE AND DISABILITY RECOGNICED BY THE INSS* IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS
Grau Garcia, E.; (...); Roman Ivorra, J.
Meeting Abstract. 10.1136/annrheumdis-2016-eular.4100. 2016
Relation Between Cumulative Damage in Systemic Lupus Erythematosus and Recognised Disability by the National Social Security Institute of Spain (INSS).
Fernández Matilla M; (...); Román Ivorra JA
Article. 10.1016/j.reuma.2019.03.003. 2019
Relationship between structural damage with loss of strength and functional disability in psoriatic arthritis patients.
Feced Olmos CM; (...); Román Ivorra JA
Article. 10.1016/j.clinbiomech.2019.06.009. 2019
Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study.
Sanchez-Diaz, M.; (...); Carrascosa-Carrillo, J. M.
Article. 10.1016/j.ad.2023.10.016. 2023
RESPONSE OF BEHCET'S REFRACTORY ORAL AND/OR GENITAL ULCERS TO APREMILAST IN COMBINATION VS MONOTHERAPY. NATIONAL MULTICENTER STUDY OF 51 CASES OF CLINICAL PRACTICE
Morant, AH; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2020-eular.6246. 2020
RESULTS IN THE FOLLOW-UP OF THE NURSING CONSULTATION FOR THE MONITORING OF RHEUMATOLOGIC PATIENTS TREATED WITH INTRAVENOUS THERAPIES
Herranz, CN; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5702. 2017
RESULTS OF EARLY INTERVENTION IN PATIENTS BEING OFF WORK DUE TO MUSCULOSKELETAL CAUSES IN THE HUP LA FE AREA
Molina Almela, C.; (...); Roman Ivorra, J. A.
Article. 10.1136/annrheumdis-2014-eular.5060. 2014
Reticular telangiectatic erythema: a reactive clinicopathological entity related to the presence of foreign body
Armengot-Carbo M, Sabater V, Botella-Estrada R
Letter. 10.1111/jdv.12707. 2016
Retrospective research of cutaneous and mucosal leishmaniasis in a Spanish hospital of an endemic zone of Leishmania donovani infantum infection
Sahuquillo, Antonio; (...); Botella, Rafael
Meeting Abstract. 2017
Review of Cutaneous Graft-vs-Host Disease.
Ballester-Sánchez R; (...); Botella-Estrada R
Article. 10.1016/j.ad.2015.10.003. 2016
RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE. MULTICENTRIC RETROSPECTIVE STUDY OF 118 PATIENTS TREATED WITH BIOLOGICAL NO ANTI TNF
Fernandez-Diaz, C; (...); Blanco, R
Meeting Abstract. 10.1136/annrheumdis-2018-eular.4986. 2018
Rhupus syndrome: Description of 9 cases with special attention to the HLA-DR genotype
Hurtado, Andres Perez; (...); Ivorraa, Jose Andres Roman
Article. 10.1016/j.medcli.2024.09.006. 2025
Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)
Tomas-Velazquez, Alejandra; (...); Redondo, Pedro
Article. 10.2340/actadv.v101.544. 2021
Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal Cell Carcinoma or Squamous Cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
Miñano Medrano R; (...); García-Doval I
Article. 10.1016/j.ad.2022.01.003. 2022
RITUXIMAB SAFETY AND PERSISTENCE IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 2020
Role of microRNAs in the pathogenesis of melanoma
Murria, Rosa; (...); Botella, Rafael
Meeting Abstract. 2017
Ruxolitinib for foreign body reaction to silicone in a patient with chronic graft-versus-host disease.
Palacios-Diaz, Rodolfo David; (...); Botella-Estrada, Rafael
Letter. 10.1111/ijd.17365. 2024
Ruxolitinib oral puede aumentar la agresividad de los carcinomas escamosos cutáneos: serie de 6 pacientes.
Lasheras-Perez MA; (...); Botella-Estrada R
Article. 10.1016/j.ad.2024.10.003. 2025
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Article. 10.1111/ajt.14580. 2018
Sarcoidosis cutánea tras inyecciones de plasma rico en plaquetas y maquillaje permanente de cejas.
Martín-Torregrosa D; (...); Botella-Estrada R
Article. 10.1016/j.ad.2024.10.043. 2024
Scaling and periorificial crusts in a pediatric patient.
Fayos-Gregori, Rafael; (...); Botella-Estrada, Rafael
Article. 10.1007/s15010-024-02309-7. 2024
Scalp Melanoma: A High-Risk Subset of Cutaneous Head and Neck Melanomas with Distinctive Clinicopathological Features.
Palacios-Diaz RD; (...); Botella-Estrada R
Article. 10.3390/jcm12247643. 2023
Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective.
Moles-Poveda, P; (...); Botella-Estrada, R
Article. 10.1016/j.ad.2017.11.003. 2018
SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound
Campos Fernandez, Cristina; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
SECONDARY PREVENTION OF VERTEBRAL FRACTURES SUSTAINED EFFICACY OVER TIME
Oller Rodriguez, J. E.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.3312. 2022
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study.
Tejera-Vaquerizo, Antonio; (...); Nagore, Eduardo
Article. 10.3390/jcm10245878. 2021
Serological Evidence of SARS-CoV-2 in Symptomatic Patients Under Biological Treatment in a Rheumatology Service
Perales, CP; (...); Ivorra, JAR
Meeting Abstract. 2020
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice
Aguas Peris M; (...); Nos, P
Article. 10.1097/MIB.0000000000001182. 2017
Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
Meeting Abstract. 2017
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations
Brittain, C; (...); Tau Restoration PSP Tauros Investi
Article. 10.1016/j.parkreldis.2018.08.025. 2019
Sex Differences in Giant Cell Arteritis: Data from the ARTESER Registry
Fernandez-Lozano, Delia; (...); Blanco, Ricardo
Meeting Abstract. 2023
SfM-3DULC: Reliability of a new 3D wound measurement procedure and its accuracy in projected area.
Sánchez-Jiménez D; (...); Botella-Estrada R
Article. 10.1111/iwj.13595. 2021
Short and Long-Term Follow-up with Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 49 Patients of Clinical Practice
Dom-Nguez-Casas, LC; (...); Blanco, R
Meeting Abstract. 2017
Single Digital Metastasis of Rectal Adenocarcinoma
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Letter. 10.1097/DAD.0000000000002529. 2023
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
Skin Cancer and the Dermatologist: Reflections on the Position Taken by the Spanish Society of Medical Oncology (SEOM).
Moreno-Ramirez, D; (...); Malvehy, J
Article. 10.1016/j.ad.2017.06.003. 2017
Skin cancer risk after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1111/ijd.17371. 2024
Skin lesions in a lung transplant recipient
Mansilla-Polo, Miguel; (...); Botella-Estrada, Rafael
Editorial Material. 10.1016/j.eimc.2023.09.005. 2024
Skin lesions in a lung transplant recipient.
Mansilla-Polo M; (...); Botella-Estrada R
Case Reports. 10.1016/j.eimce.2023.09.005. 2024
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma.
Sanmartín O; (...); Puig S
Review. 10.1016/j.ad.2020.11.002. 2021
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
González-Álvaro I; (...); Spanish Rheumatology Society
Article. 10.1093/rheumatology/keu461. 2015
Staging and follow-up of patients with melanoma: which tests for which patients?
Botella Estrada R, Escutia Muñoz B
Article. 10.1016/j.ad.2013.11.002. 2014
Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain
Gratacos, J; (...); Queiro, R
Article. 10.1007/s00296-018-3986-4. 2018
State of the art of Mohs surgery for rare cutaneous tumors in the Spanish Registry of Mohs Surgery (REGESMOHS).
Rodríguez-Jiménez P; (...); Descalzo MA
Article. 10.1111/ijd.14732. 2020
Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta
Ramos Castro, Daniel; (...); Roman-Ivorra, Jose A.
Meeting Abstract. 2024
Study of Microsatellite Instability by Immunohistochemistry in a Cohort of Patients With Melanoma
Diaz, Rodolfo David Palacios; (...); Estrada, Rafael Botella
Article. 10.1111/cup.14758. 2025
STUDY OF THE EFFECTIVENESS OF IMATINIB IN CHRONIC GRAFT-VERSUS-HOST DISEASE IN A SERIES OF 19 CASES
Poveda, PM; (...); Caballer, JS
Meeting Abstract. 2017
Study of the Immunophenotype of the Inflammatory Cells in Melanomas With Regression and Halo Nevi
Botella-Estrada R, Kutzner H
Article. 10.1097/DAD.0000000000000205. 2015
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
Successful treatment of erythema nodosum leprosum with apremilast.
Abril-Perez, Carlos; (...); Botella-Estrada, Rafael
Letter. 10.1111/dth.15258. 2022
Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast.
Mansilla-Polo, Miguel; (...); Torres-Navarro, Ignacio
Letter. 10.1111/ijd.17293. 2024
Successful treatment of field of cancerization in the dorsum of the hands with 1% tirbanibulin ointment.
Abril-Perez, Carlos; (...); Botella-Estrada, Rafael
Article. 10.1093/ced/llad171. 2023
Successful Treatment of Mogamulizumab-Associated Rash With Upadacitinib: Evidence From 2 Cases.
Martin-Torregrosa, Daniel; (...); Botella-Estrada, Rafael
Article. 10.1001/jamadermatol.2024.4582. 2024
Successful Treatment of Stimulator of Interferon Genes-Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab.
Mansilla-Polo M; (...); Botella-Estrada R
Article. 10.1001/jamadermatol.2024.2160. 2024
Successful treatment with imatinib of lymphomatoid papulosis associated with myeloproliferative hypereosinophilic syndrome with PDGFRA rearrangement.
Torres-Navarro I; (...); Botella-Estrada R
Case Reports. 10.1111/ddg.14064. 2020
Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo, A; (...); SENTIMEL group
Article. 10.1002/cam4.2358. 2019
Sustained Drug-Free Remission in Giant Cell Arteritis.
Narvaez, Javier; (...); Blanco, Ricardo
Article. 10.1093/rheumatology/keae644. 2024
Sustained Drug-free Remission in Giant Cell Arteritis: Results Results of the Spanish ARTESER Registry
Narvaez-Garcia, Javier; (...); Blanco-Alonso, Ricardo
Meeting Abstract. 2024
Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.
Lasheras-Pérez MA; (...); Rodriguez-Serna M
Article. 10.1111/ijd.16926. 2024
Symmetrical pustulosis unfolds over systemic lupus.
Abril-Perez, Carlos; (...); Botella-Estrada, Rafael
Article. 10.1093/rheumatology/keab529. 2021
Systematic review of BRAF/MEK inhibitors-induced Severe Cutaneous Adverse Reactions (SCARs).
Torres-Navarro I, de Unamuno-Bustos B, Botella-Estrada R
Review. 10.1111/jdv.16894. 2020
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH POSITIVES AUTOANTIBODIES WITH REMISSION OR LOW ACTIVITY EXHIBIT BOTH LOWER INTERFERON ALPHA AND INTERLEUKIN-10 LEVELS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2017-eular.5766. 2017
Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis.
Torres-Navarro I, Briz-Redón Á, Botella-Estrada R
Review. 10.1111/jdv.16685. 2020
Systemic therapies for toxic epidermal necrolysis and Stevens-Johnson syndrome: A SCORTEN-based systematic review and meta-analysis
Torres Navarro, Ignacio; (...); Botella-Estrada, Rafael
Meeting Abstract. 2020
Tattoo-Associated Common Wart
Mansilla-Polo, M., Llavador-Ros, M., Botella-Estrada, R.
Editorial Material. 10.1016/j.ad.2024.05.001. 2024
Tattoo-Associated Common Wart.
Mansilla-Polo, M, Llavador-Ros, M, Botella-Estrada, R
Article. 10.1016/j.ad.2023.04.037. 2023
Telomerase Expression in a Series of Melanocytic Neoplasms
Bustos, BD; (...); Estrada, RB
Article. 10.1016/j.ad.2018.10.003. 2019
The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil
Armengot-Carbo, M; (...); Botella-Estrada, R
Article. 10.1016/j.jaad.2017.12.064. 2018
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The Female Sexual Function Index to assess patients with moderate to severe vulvar lichen sclerosus.
Gutierrez-Ontalvilla P; (...); Vicente D
Letter. 10.1684/ejd.2019.3580. 2019
The impact of disease activity on health-related quality of life in patients with systemic lupus erythematosus.
Grau García E; (...); Román Ivorra JA
Article. 10.1016/j.medcli.2022.11.019. 2023
The presence of both HLA-DRB1*04:01 and HLA-B*15:01 increases the susceptibility to cranial and extracranial giant cell arteritis
Prieto-Pena, D; (...); Gonzalez-Gay, MA
Article. 2021
The presence of both HLA-DRB1[*]04:01 and HLA-B[*]15:01 increases the susceptibility to cranial and extracranial giant cell arteritis.
Prieto-Peña D; (...); González-Gay MA
Article. 2021
The role of 18F-FDG PET/CT in early infectious discitis: a case report after a negative MRI.
Fragío-Gil JJ; (...); Román-Ivorra JA
Case Reports. 10.1016/j.radcr.2019.04.006. 2019
THE ROLE OF CXCL4, CXCL8 AND GDF-15 IN SYSTEMIC SCLEROSIS
Rodriguez, JEO; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2020-eular.5019. 2020
The role of phototherapy in cutaneous chronic graft-vs-host disease: a retrospective study and review of the literature.
Ballester-Sánchez R; (...); Botella-Estrada R
Article. 10.1016/j.ad.2015.04.009. 2015
The Role of Plasma Calprotectin in Non-infectious Uveitis.
Pascual EV; (...); Ivorra JAR
Article. 10.1080/02713683.2020.1867749. 2021
The use of the vessel loop to bolster mattress sutures and prevent scars
MOLES, P.; (...); Botella-Estrada R
Editorial Material. 10.1016/j.jaad.2017.10.031. 2018
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus
Torrent-Farnell, J; (...); Lizan, L
Article. 10.1016/j.healthpol.2018.03.002. 2018
Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients.
Altabás-González I; (...); Rúa-Figueroa I
Article. 10.1093/rheumatology/kead696. 2024
TOCILIZUMAB FOR TAKAYASU ARTERITIS: MULTICENTER STUDY OF 54 WHITE PATIENTS
Prieto-Pena, D; (...); Blanco, R
Meeting Abstract. 10.1136/annrheumdis-2021-eular.1747. 2021
Tocilizumab in Caucasian Patients with Takayasu Arteritis: Multicenter Study of 54 Patients
Prieto-Pena, Diana; (...); Blanco, Ricardo
Meeting Abstract. 2021
Tocilizumab in Giant Cell Arteritis. National Multicenter Study of 134 Patients of Clinical Practice
Goercke, MC; (...); Blanco, R
Meeting Abstract. 2018
Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice
Calderon-Goercke, M; (...); Blanco, R
Article. 10.1016/j.semarthrit.2019.01.003. 2019
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice
Calderon-Goercke, M; (...); Blanco, R
Article. 2020
Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice.
Calderón-Goercke M; (...); Blanco R
Article. 2020
Tocilizumab in Giant Cell Arteritis: Route of Administration: Intravenous or Subcutaneous
Calderon-Goercke, Monica; (...); Blanco, Ricardo
Meeting Abstract. 2019
Tocilizumab in Giant Cell Arteritis: The Safest and Most Effective Initial Dose of Prednisone
Calderon-Goercke, Monica; (...); Blanco, Ricardo
Meeting Abstract. 2019
TOCILIZUMAB IN LARGE-VESSEL GIANT CELL ARTERITIS AND TAKAYASU ARTERITIS: MULTICENTRIC OBSERVATIONAL COMPARATIVE STUDY
Prieto-Pena, D.; (...); Blanco, R.
Meeting Abstract. 10.1136/annrheumdis-2022-eular.2330. 2022
Tocilizumab in patients with active rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs or tumor necrosis factor inhibitors: subanalysis of Spanish results of an open-label study close to clinical practice.
Alvaro-Gracia JM; (...); ACT SURE
Article. 10.1016/j.reuma.2013.07.002. 2014
Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review
Prieto-Pena, Diana; (...); Blanco, Ricardo
Article. 10.1177/1759720X211020917. 2021
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel
de Unamuno Bustos B; (...); Botella Estrada R
Article. 10.1038/s41598-017-00606-w. 2017
Toxic epidermal necrolysis with severe hepatic involvement
Torres-Navarro, I; (...); Botella-Estrada, R
Letter. 10.1111/ddg.14110. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Toxische epidermale Nekrolyse mit schwerer hepatischer Beteiligung.
Torres-Navarro I; (...); Botella-Estrada R
Letter. 10.1111/ddg.14110_g. 2020
Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.
Megías Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.rx.2015.01.008. 2015
TRANSITIONAL CARE IN JUVENILE IDIOPATHIC ARTHRITIS: TIMING, PREVALENCE OF SUBTYPES AND TREATMENT PROFILE IN A SPANISH TERTIARY HOSPITAL.
Perales, C. Pavez; (...); Ivorra, J. A. Roman
Meeting Abstract. 10.1136/annrheumdis-2022-eular.4126. 2022
Treatment of Giant Cell Arteritis in the ARTESER Multicenter Study of 1675 Patients
Sanchez-Costa, Jesus T.; (...); Blanco, Ricardo
Meeting Abstract. 2021
Treatment of palmoplantar psoriasis with oral roflumilast: a case series.
Lasheras-Perez, Miguel Antonio; (...); Botella-Estrada, Rafael
Article. 10.1093/ced/llae229. 2024
Treatment Persistence and Safety of Apremilast in Psoriasis: Experience With 30 Patients in Routine Clinical Practice
Sahuquillo-Torralba, A; (...); Estrada, RB
Article. 10.1016/j.ad.2018.10.031. 2020
TREATMENT WITH TOFACITINIB IN REFRACTORY PSORIATIC ARTHRITIS. MULTICENTER STUDY OF CLINICAL PRACTICE
Martin-Varillas, JL; (...); Blanco, R
Meeting Abstract. 10.1136/annrheumdis-2019-eular.7803. 2019
Treatment With Tofacitinib in Refractory Psoriatic Arthritis: A National Multicenter Study of the First 87 Patients in Clinical Practice.
Galíndez-Agirregoikoa E; (...); Tofacitinib PsA Clinical Practice Collaborative Group
Article. 10.3899/jrheum.201204. 2021
TREATMENT, ADVERSE EVENTS AND FOLLOW UP IN PATIENTS WITH GIANT CELL ARTERITIS IN THE ARTESER MULTICENTER STUDY
Sanchez-Costa, J. T.; (...); Blanco, R.
Article. 10.1136/annrheumdis-2022-eular.1314. 2022
Treat-to-Target Strategy in Patients with Rheumatoid Arthritis: Audit of Adherence from Real World Clinical Data.
Andréu JL; (...); Gil de Miguel Á
Article. 10.1016/j.reuma.2019.10.006. 2019
Tumour-infiltrating lymphocyte and histological regression in primary melanoma.
Ribero S, Torres-Navarro I, Botella-Estrada R
Letter. 10.1007/s00403-020-02089-8. 2021
Two years results of electronic brachytherapy for basal cell carcinoma
Ballester-Sánchez R; (...); Botella-Estrada, R
Article. 10.5114/jcb.2017.68191. 2017
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Update on melanoma epigenetics
de Unamuno B, Palanca S, Botella R
Review. 10.1097/CCO.0000000000000217. 2015
Urticaria multiforme, an "erythema multiforme" simulator.
Torres-Navarro I, Sahuquillo-Torralba A, Botella-Estrada R
Article. 10.1016/j.medcli.2017.11.046. 2018
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients
García-Robles AA; (...); Poveda JL
Letter. 10.1016/j.jns.2016.04.048. 2016
Use of an electrospun bioveil is safe and does not decrease skin graft take on burn wounds: A randomised, controlled clinical trial.
Perez-Del-Caz, Maria Dolores; (...); Perez-Plaza, Aranzazu
Article. 10.1016/j.burns.2025.107427. 2025
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
USE OF RITUXIMAB IN SYSTEMIC SCLEROSIS PATIENTS WITH PULMONARY AND DIFFUSE CUTANEOUS INVOLVEMENT. A SERIES OF 15 CASES
Ortiz Sanjuan, F.; (...); Roman Ivorra, J. A.
Meeting Abstract. 10.1136/annrheumdis-2023-eular.2961. 2023
Usefulness of ultrasound in Jaccoud's arthropathy. A case report.
Olmos, CMF; (...); Ivorra, JAR
Letter. 10.1016/j.reuma.2014.08.002. 2015
UTILITY OF APREMILAST IN REFRACTORY ORAL AND/OR GENITAL ULCERS IN BEHCET'S DISEASE
Atienza-Mateo, B; (...); Blanco, R
Meeting Abstract. 10.1136/annrheumdis-2018-eular.2542. 2018
Utility of cytokines CXCL4, CXCL8 and GDF15 as biomarkers in systemic sclerosis.
Oller-Rodriguez, Jose E.; (...); Roman Ivorra, Jose A.
Article. 10.1016/j.medcli.2021.12.006. 2022
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
Vascular endothelial growth factor haplotypes are associated with severe ischaemic complications in giant cell arteritis regardless of the disease phenotype.
Prieto-Pena, D.; (...); Gonzalez-Gay, M. A.
Article. 10.55563/clinexprheumatol/8mku9c. 2022
VERTEBRAL OSTEOMYELITIS IN THE IMMUNOSUPPRESSED PATIENTS
Fragio-Gil, JJ; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.6621. 2019
Vertebral osteomyelitis: Clinical, microbiological and radiological characteristics of 116 patients
Gil, JJF; (...); Ivorra, JAR
Article. 10.1016/j.medcli.2019.12.029. 2020
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic Arthritis
Queiro, R; (...); Morla, R
Article. 10.3899/jrheum.180460. 2019
Visual Manifestations in Giant Cell Arteritis: Identification of Risk Factors from the ARTESER Registry
Molina-Collada, Juan; (...); Blanco, Ricardo
Meeting Abstract. 2023
VITAMIN D SUPPLEMENTATION IN LIVER TRANSPLANT PATIENTS
Valero Sanz, J. L.; (...); Roman Ivorra, J. A.
Article. 10.1136/annrheumdis-2014-eular.5072. 2014
Vulvar and areolar fixed drug eruption.
Abril-Pérez C; (...); Botella-Estrada R
Article. 10.1016/j.ajog.2021.09.042. 2021
Women with moderate-to-severe psoriasis in Spain (BIOBADADERM registry) show more than a 50% reduction in age-adjusted fertility rate when compared with the general population.
Gonzalez-Cantero, A.; (...); Garcia-Doval, I.
Letter. 10.1111/bjd.18164. 2019
Zoon's vulvitis in association with severe vulvodynia.
Abril-Perez, Carlos; (...); Botella-Estrada R
Article. 10.1016/j.ajog.2022.01.033. 2022